Predictive Oncology raises $1.26M via warrant exercise at reduced price; issues new warrants

Axe Compute Inc.

Gross proceeds of $1.26M from immediate cash exercise of 958,117 warrants at $1.32/share (down from $14.00).
Issued new Series A (5-yr) and Series B (18-mo) warrants, each for 958,117 shares, with $1.07 exercise price.
H.C. Wainwright placement agent: 7% cash fee plus 67,068 warrants at $1.65/share.
Net proceeds combined with $3.58M from May 2024 ATM offering for working capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.